Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Times Interest Earned (2022 - 2025)

Historic Times Interest Earned for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $2.78.

  • Arcutis Biotherapeutics' Times Interest Earned rose 14728.07% to $2.78 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.61, marking a year-over-year increase of 5779.38%. This contributed to the annual value of -$4.73 for FY2024, which is 4175.88% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Times Interest Earned stood at $2.78 for Q3 2025, which was up 14728.07% from -$4.82 recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Times Interest Earned high stood at $2.78 for Q3 2025, and its period low was -$34.07 during Q1 2022.
  • Moreover, its 4-year median value for Times Interest Earned was -$7.88 (2023), whereas its average is -$10.63.
  • The largest annual percentage gain for Arcutis Biotherapeutics' Times Interest Earned in the last 5 years was 14728.07% (2025), contrasted with its biggest fall of 9457.38% (2025).
  • Arcutis Biotherapeutics' Times Interest Earned (Quarter) stood at -$9.9 in 2022, then rose by 20.36% to -$7.88 in 2023, then skyrocketed by 82.55% to -$1.37 in 2024, then surged by 301.93% to $2.78 in 2025.
  • Its Times Interest Earned stands at $2.78 for Q3 2025, versus -$4.82 for Q2 2025 and -$8.23 for Q1 2025.